Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer.

Int J Mol Sci · 2022 · PMC9656504 · PMID 36362023

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Intriguingly, the number of CD68+/PD-L1+/CK-/CD163- sTAMs in the stromal area did not affect the recurrence rate, whereas that of CD163+/PD-L1+/CK- sTAMs, which are assumed to have potential as M2 macrophages, showed a trend toward poor prognosis, although the difference was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.